← Leaderboards
Ronald L Nagel
Yeshiva University
$7,416,455
Attributed
$7,416,455
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.4M · FY2005–08$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$28,951,178 · 14
By mechanism
P01$12,088,912 · 2
U54$5,868,223 · 2
P60$5,589,745 · 2
R01$4,146,562 · 1
T32$992,162 · 1
M01$265,574 · 6
Top collaborators
No co-investigators on record.
Most similar at Yeshiva University
Same institution · by research overlap
- Philippe Leboulch$5,901,573
- Joel M Friedman$9,068,244
- Eric E Bouhassira$12,700,042
- Mary E Fabry$5,134,014
- Frank A Ferrone$3,953,262
Others in their field
Top investigators on “Sickle Cell Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Martin H. Steinberg · Boston Medical Center$25,628,557
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
- Barbara L Kroner · Research Triangle Institute$21,141,016
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
Research focus
Sickle Cell AnemiaClinical ResearchGene TherapyHemoglobin SsHuman SubjectLaboratory MouseBiotechnologyGenetically Modified AnimalsGene ExpressionProtein Structure FunctionDisease /Disorder ModelHemoglobin CChemical ModelsBlood Vessel OcclusionErythrocytesAtomic Absorption SpectrometryCrystallizationCell MorphologyFluorescence SpectrometryGenetic PolymorphismCellular PathologyErythrocyte MembraneConformationEye Circulation Disorder
Grant awards (43)
SICKLE CELL$7,850
M01 · FY2008 · RR · contact PI
Administrative Core$298,617
U54 · FY2007 · HL · contact PI
SICKLE CELL$51,811
M01 · FY2007 · RR · contact PI
Bronx Comprehensive Sickle Cell Center$1,510,294
U54 · FY2006 · HL · contact PI
Bronx Comprehensive Sickle Cell Center$97,650
U54 · FY2006 · HL · contact PI
Training in Research in Red Blood Cell Diseases$43,993
T32 · FY2006 · HL · contact PI
SICKLE CELL$38,163
M01 · FY2006 · RR · contact PI
Bronx Comprehensive Sickle Cell Center$1,397,815
U54 · FY2005 · HL
Pleiotropic and epistatic effects in sickle cell anemia$815,560
R01 · FY2005 · HL
Training in Research in Red Blood Cell Diseases$144,544
T32 · FY2005 · HL
SICKLE CELL ANEMIA$76,576
M01 · FY2005 · RR
GENE THERAPY FOR SICKLE CELL ANEMIA$2,465,735
P01 · FY2004 · HL
Bronx Comprehensive Sickle Cell Center$1,400,550
U54 · FY2004 · HL
Pleiotropic and epistatic effects in sickle cell anemia$815,560
R01 · FY2004 · HL
Training in Research in Red Blood Cell Diseases$244,380
T32 · FY2004 · HL
SICKLE CELL ANEMIA$91,174
M01 · FY2004 · RR
GENE THERAPY FOR SICKLE CELL ANEMIA$2,391,557
P01 · FY2003 · HL
Bronx Comprehensive Sickle Cell Center$1,163,297
U54 · FY2003 · HL
Pleiotropic and epistatic effects in sickle cell anemia$815,560
R01 · FY2003 · HL
Training in Research in Red Blood Cell Diseases$242,457
T32 · FY2003 · HL
Human ES Cells: A Model to test Gene Therapy Vectors$83,500
P01 · FY2003 · HL
GENE THERAPY FOR SICKLE CELL ANEMIA$1,884,934
P01 · FY2002 · HL
COMPREHENSIVE SICKLE CELL CENTER$1,617,294
P60 · FY2002 · HL
Pleiotropic and epistatic effects in sickle cell anemia$815,560
R01 · FY2002 · HL
Gene Therapy of Sickle Cell Anemia &Beta-Thalassemia$488,459
P01 · FY2002 · HL
NOVEL ANTI-SICKLING STRATEGIES: GLOBINS AND RIBOZYMES$266,631
P01 · FY2002 · HL
NOVEL ANTI-SICKLING STRATEGIES: GLOBINS AND RIBOZYMES$266,631
P01 · FY2002 · HL
Training in Research in Red Blood Cell Diseases$234,215
T32 · FY2002 · HL
MOLECULAR PATHOLOGY OF HBC AND SICKLE CELL DISEASE$175,153
P60 · FY2002 · HL
MOLECULAR PATHOLOGY OF HBC AND SICKLE CELL DISEASE$175,153
P60 · FY2002 · HL
COMPREHENSIVE SICKLE CELL CENTER$8,800
P60 · FY2002 · HL
GENE THERAPY FOR SICKLE CELL ANEMIA$1,841,786
P01 · FY2001 · HL
COMPREHENSIVE SICKLE CELL CENTER$1,659,955
P60 · FY2001 · HL
Pleiotropic and epistatic effects in sickle cell anemia$884,322
R01 · FY2001 · HL
NOVEL ANTI-SICKLING STRATEGIES: GLOBINS AND RIBOZYMES$266,631
P01 · FY2001 · HL
MOLECULAR PATHOLOGY OF HBC AND SICKLE CELL DISEASE$175,153
P60 · FY2001 · HL
GENE THERAPY FOR SICKLE CELL ANEMIA$0
M01 · FY2001 · RR
GENE THERAPY FOR SICKLE CELL ANEMIA$1,866,417
P01 · FY2000 · HL
COMPREHENSIVE SICKLE CELL CENTER$1,656,680
P60 · FY2000 · HL
NOVEL ANTI-SICKLING STRATEGIES: GLOBINS AND RIBOZYMES$266,631
P01 · FY2000 · HL
MOLECULAR PATHOLOGY OF HBC AND SICKLE CELL DISEASE$121,557
P60 · FY2000 · HL
TRAINING IN RESEARCH IN RED BLOOD CELL DISEASES$82,573
T32 · FY2000 · HL
GENE THERAPY FOR SICKLE CELL ANEMIA$0
M01 · FY2000 · RR